PMID: 19093334Dec 20, 2008

Multiple myeloma: epidemiology and therapeutic options

Managed Care
Joseph M Tuscano

Abstract

Myeloma remains an incurable disease, but its management has significantly improved with the introduction of novel treatment agents. Variations in both disease manifestation and patient response to treatment have personalized approaches to care.

Related Concepts

Lenalidomide
Antineoplastic Chemotherapy Protocols
Incurable Diseases
Hemopoietic Stem Cell Transplant
Epidemiology
Clinical Oncology
Thalomid
Oradexon
Multiple Myeloma
Patient Care Management

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.